|
| |
Image Results
Loading...
Loading...
Elan S Nanocrystal Technology Commercialization Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Elan Pharmaceuticals And EntreMed, Inc. Execute License Agreement ...
EntreMed President and Chief Executive Officer, James S. Burns commented, ... Elan's NanoCrystal Technology is a novel drug delivery technology that offers
superior ... future capital needs; and risks relating to the commercialization,
...
http://www.biospace.com/news_story.aspx?NewsEntityId=6570...
|
The art of partnering : Article : Nature Reviews Drug Discovery
These currently involve the out-licensing of Elan's drug delivery technologies, including the use of Nanocrystal Technology and other more traditional ...
http://www.nature.com/uidfinder/10.1038/nrd2370...
|
Elan Reports Third Quarter 2009 Financial Results - Yahoo! Finance
21 Oct 2009 ... Elan CEO Kelly Martin said, “The third quarter. ... {"s" : "eln","k" : "c10,l10, p20,t10","o" : "","j" : ""} ..... infrastructure that would enable Elan to
accelerate the development and commercialization of its .... approved by the FDA
using Elan's NanoCrystal® technology for various formulations. ...
http://biz.yahoo.com/bw/091021/20091020006940.html?.v=1...
|
AstraZeneca and MAP Pharmaceuticals Announce Worldwide ...
19 Dec 2008 ... including for paediatric asthma,” said Timothy S. Nelson, President and Chief ... utilising a license to Elan's proprietary NanoCrystal® Technology. ...
on their known safety, efficacy and commercialization history. ...
http://www.astrazeneca.com/media/latest-press-releases/2008/...
|
1 6-1 Polymerized Colloidal Array Photonic Crystal Chemical ...
witnessed the advent, prototyping and commercialization of quantum dot based products. ... 5.4 + 0.7 x 101 M-1s-1 and kr = 1.5 + 0.4 x 10-4 s-1) comparable
to ..... 19406, Liversidge, elaine.liversidge@elan.com. NanoCrystal® Technology
...
http://www.clarkson.edu/camp/acs/docs/Session%206%20-%20Text...
|
Auto-immune disease (non-specific) - BioSpace offers ...
Xencor Presents Findings on New Aspect of its Fc Technology Targeting Autoimmune Disease 12/7/2007 .... PK) Sign Worldwide Agreement To Develop And Commercialize
HuMax-TAC; ... Elan Corporation PLC (ELN) And Roche (RHHBY) Expand Nanocrystal
... Research On Metaphore Pharmaceuticals, Inc.'s Lead Pain Management Drug ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...
|
Microsoft PowerPoint - Constantinides_2009_QbD_Conference_Israel ...
20 Apr 2009 ... Nanocrystal. Nanocrystal® Technology : ® Technology : Marketed Drug Products ..... Drivers for future growth and commercialization include : ...
http://www.pharmacy.wisc.edu/esp/prog/IsraelQbD/Constantinid...
|
Characterization of Nanoparticles for Therapeutics: Abstract and ...
29 May 2008 ... characterization has been a rate-limiting phase of the commercialization process. ..... Prabha S, Zhou WZ, Panyam J, Labhasetwar V: Size-dependency of
... Approved 9/15/1999 FDA21083, Elan/Wyeth. Emend®, Nanocrystal/aprepitant ...
Advanced Technology Program, NCI-Frederick, 1050 Boyles St., ...
http://www.medscape.com/viewarticle/574912...
|
Intelligent Polymerized Crystalline Colloidal Array Photonic ...
When conjugated to DNA, the nanocrystal-micelles act as in vitro fluorescent probes to .... prototyping and commercialization of quantum dot based products.
.... The prepared Y2O2S powders are chemically stable in the dried form, .....
19406, Liversidge, elaine.liversidge@elan.com. NanoCrystalâ Technology is a ...
http://www.clarkson.edu/camp/acs/docs/Session%206%20-%20Text...
|
Microsoft PowerPoint - NWG-NCLDowning
15 Mar 2006 ... Nanocrystals. Nanotech “Toolbox” for Cancer Products. Modality .... Elan/Wyeth. Emend nanocrystalline drug nausea approved ... s s. 1) 'Nano' in-vitro sensors.
Earlier diagnostics ... development and commercialization ... Partnership with
National Institutes of Standards and Technology and U.S. ...
http://ntp.niehs.nih.gov/index.cfm?objectid=83AD0BC1-F1F6-97...
|
|
